Foxi3^em2Ybz

CRISPR/Cas9 technology generated a G to A change resulting in an arginine to histidine substitution at amino acid 224 (p.R224H). This is equivalent to the human p.R240H pathogenic variant identified in a Chinese family with Goldenhar syndrome (craniofacial microsomia). (J:336768)